Clinical trials are an integral component of healthcare research, providing a platform to test new drugs, procedures, and medical devices before they become available to the public. These trials are essential for evaluating the safety and efficacy of treatments, identifying potential side effects and risks, and enhancing patient outcomes. With thousands of clinical trials conducted worldwide, covering diverse health conditions ranging from cancer to rare genetic disorders, the potential to transform healthcare and improve lives globally is immense.
CURRENT CLINICAL TRIALS WITH SKIN CANCER & DERMATOLOGY INSTITUTE
Abbvie M19-977, enrolling adolescents with moderate to severe psoriasis,
Amgen 20210143, enrolling adults with moderate to severe atopic dermatitis,
and Amgen 20210145, enrolling adolescents with the same condition.
Castle is an observational study aiming to identify genetic markers and patient response to systemic meds.
COMING SOON
The Sotyktu study aims to collect quality-of-life data for patients with moderate to severe psoriasis needing a biologic.
If you are interested in referring a patient or learning more about participating in a clinical trial, please contact us at 775.336.3665.
All study participants receive free drugs and compensation for their visits. Joining a clinical trial is an excellent way to contribute to medical research and help advance healthcare for everyone.
Currently at Skin Cancer and Dermatology Institute we are offering several different studies treating Atopic dermatitis/eczema, Psoriasis, Hidradenitis, Notalgia paresthetica, Alopecia areata, and Alopecia totalis.
These studies are phase three studies offering cutting edge treatment for the above mentioned conditions aimed to treat both adolescents and adults.
We do offer a number of non-treatment studies as well aimed to follow patients who are currently on biologic therapy for their different skin conditions. This study is designed to observe safety data while they switch to different treatment modalities.
We also following patients who have been diagnosed with melanoma to follow their long term outcome.
If you would like more information please feel free to directly reach out to our research team at 775-336-3665.